Health claim
“Long‑term use of semaglutide may reduce the incidence of age‑related diseases like type 2 diabetes and fatty liver disease.”
Claim extracted — not yet reviewedHigh riskmedications
This claim has been extracted from the video but has not yet been fully reviewed against published evidence. Treat with appropriate caution.
Evidence Summary
This claim has not yet been reviewed against the literature.
The video cites prevention of metabolic disorders as a longevity benefit.
Extracted from
Could Ozempic Help You Live Longer? | Lifespan with Dr. David Sinclair - S2, Ep. 10David Sinclair
The video discusses the potential of Ozempic (semaglutide) for extending lifespan, featuring insights from Dr. David Sinclair while examining current scientific evidence and limitations.
Watch breakdown →